Minerva Neurosciences, Inc.(NERV)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Minerva Neurosciences, Inc. (NERV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NERV is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $41.2m in revenue and is scored on the micro-cap board instead. Top institutional holders of NERV by reported 13-F value include FEDERATED HERMES, Jupiter Topco, Vivo Capital, based on the most recent SEC filings. NERV trades on the Nasdaq exchange and files with the SEC under CIK 1598646. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NERV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Minerva Neurosciences, Inc. directly from SEC EDGAR.

Net Income

$17.5M

NERV key financials by period

Minerva Neurosciences, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202010-K$41.2M$1.9M4.5%

Institutions holding NERV

Institutional investors reporting a position in Minerva Neurosciences, Inc. on SEC Form 13F.
InstitutionSharesValueReported
FEDERATED HERMES4,670,426$25.9M2026-06-30
Jupiter Topco4,386,027$24.3M2026-06-30
Vivo Capital4,322,747$24.0M2026-06-30
BALYASNY ASSET MANAGEMENT L.P.4,257,000$23.6M2026-06-30
Logos Global Management3,288,777$18.3M2026-06-30
FARALLON CAPITAL MANAGEMENT2,365,000$13.1M2026-06-30
BlackRock2,240,578$12.4M2026-06-30
Ally Bridge Group (NY)2,175,802$12.1M2026-06-30
Foresite Capital Management VI1,985,584$11.0M2026-06-30
VANGUARD CAPITAL MANAGEMENT1,892,807$10.5M2026-06-30
SEC EDGAR: CIK 1598646 →
NERV

Minerva Neurosciences, Inc.

NERV
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $41.2M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$17.47M

EPS (Diluted)

Q2 2026
EDGAR

$-0.14

Top Institutional Holders

as of Q2 2026
$234.82M total
FEDERATED HERMES, INC.
$25.92M-8.7%
Jupiter Topco LLC
$24.32MNew
Vivo Capital, LLC
$23.99M0.0%
BALYASNY ASSET MANAGEMENT L.P.
$23.63M0.0%
Logos Global Management LP
$18.25M+2.3%
FARALLON CAPITAL MANAGEMENT LLC
$13.13M0.0%
BlackRock, Inc.
$12.44M+258.6%
Ally Bridge Group (NY) LLC
$12.08M+31.4%
Foresite Capital Management VI LLC
$11.02M-0.1%
VANGUARD CAPITAL MANAGEMENT LLC
$10.51M+2.5%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…